In a volatile stock market, few sectors offer as much comfort as pharmaceuticals. The defensive sec…

Condom manufacturer Mankind Pharma is likely to announce the allotment status of its initial public…

The public debut of Mankind Pharma has enriched its investors and promoters alike.

The IPO will comprise an offer for sale (OFS) of over 4 crore equity shares by the promoters a…

After listing at a 20% premium, condom manufacturer Mankind Pharma’s stock ran up 9.5% on Tuesday. …

The initial share sale of drug maker Mankind Pharma will open for public subscription on April 25.

The Association of Mutual Funds in India (AMFI) releases reclassification of largecap, midcap an…

Riding high on the positive momentum seen in 2021, many stocks gave stellar returns to investors…

India’s benchmark indices Sensex and Nifty50 are likely to open on a tepid note on Tuesday amid mix…

After a lull period of over four months in 2023, the stellar debut of Mankind Pharma has rekindled …

Grasim Paints, JSW Steel, Cipla gained over 1% each, while Asian Paints and Tata Motors gained lead…

The Income Tax department on Thursday conducted searches on the premises of Mankind Pharma over all…

Condom manufacturer Mankind Pharma has filed its draft red herring prospectus (DRHP) papers with ma…

Indian stock market indices are scaling new highs every day with the Nifty having scaled Mt 21,000 …

Mankind Pharma on Wednesday said it has inked a pact with Dr Reddy's Laboratories to acquire two br…

How pharmaceutical giant Mankind Pharma has pivoted its marketing strategy

It features Angad Bedi

Vijay Sethupathi is one of the most popular and acclaimed actors of South Indian cinema

Thanks to the bull run which has also seen the market change its view on new-age companies — the ye…